Creative Planning
NVCR icon

Creative Planning’s NovoCure NVCR Stock Holding History

Creative Planning’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$650K Buy
42,880
+22,137
+107% +$335K ﹤0.01% 2985
2026
Q1 		$226K Buy
20,743
+5,219
+34% +$65.2K ﹤0.01% 3648
2025
Q4 		$201K Sell
15,524
-4,518
-23% -$58K ﹤0.01% 3552
2025
Q3 		$259K Buy
20,042
+4,595
+30% +$61.4K ﹤0.01% 3267
2025
Q2 		$275K Sell
15,447
-1,267
-8% -$22.1K ﹤0.01% 2969
2025
Q1 		$298K Sell
16,714
-460
-3% -$10.4K ﹤0.01% 2757
2024
Q4 		$512K Buy
17,174
+1,629
+10% +$34.5K ﹤0.01% 2203
2024
Q3 		$243K Buy
15,545
+336
+2% +$6.09K ﹤0.01% 2700
2024
Q2 		$261K Buy
15,209
+5,156
+51% +$90.7K ﹤0.01% 2480
2024
Q1 		$157K Buy
+10,053
New +$148K ﹤0.01% 2622
2023
Q3 		– Sell
-6,024
Closed -$250K – 2993
2023
Q2 		$250K Sell
6,024
-490
-8% -$30.4K ﹤0.01% 2047
2023
Q1 		$392K Buy
6,514
+209
+3% +$16.7K ﹤0.01% 1636
2022
Q4 		$462K Buy
+6,305
New +$474K ﹤0.01% 1471
2022
Q2 		– Sell
-30
Closed -$2K – 2455
2022
Q1 		$2K Buy
+30
New +$2.21K ﹤0.01% 2302
2021
Q3 		– Sell
-1,341
Closed -$297K – 2189
2021
Q2 		$297K Sell
1,341
-515
-28% -$100K ﹤0.01% 1569
2021
Q1 		$245K Sell
1,856
-3,931
-68% -$622K ﹤0.01% 1930
2020
Q4 		$1M Buy
+5,787
New +$792K ﹤0.01% 948
2017
Q3 		– Sell
-1,000
Closed -$17K – 3101
2017
Q2 		$17K Sell
1,000
-15,857
-94% -$205K ﹤0.01% 3279
2017
Q1 		$137K Buy
16,857
+4,100
+32% +$29.6K ﹤0.01% 1750
2016
Q4 		$100K Buy
12,757
+2,207
+21% +$17.8K ﹤0.01% 1866
2016
Q3 		$90K Buy
10,550
+5,252
+99% +$47.9K ﹤0.01% 1920
2016
Q2 		$62K Buy
5,298
+5,098
+2,549% +$63.8K ﹤0.01% 1988
2016
Q1 		$3K Hold
200
– – ﹤0.01% 3823
2015
Q4 		$4K Buy
+200
New +$4.78K ﹤0.01% 3797

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Creative Planning's NVCR Position: Q2 2026 in Review

Creative Planning increased its NovoCure (NVCR) stake by 107% in Q2 2026, buying an estimated $335K and bringing the position to 42,880 shares worth $650K. The position accounts for ﹤0.01% of the portfolio, ranked #2985.

Creative Planning first reported a position in NVCR in Q4 2015 and has held it in 24 quarters since. The position peaked at $1M in Q4 2020. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Creative Planning held 42,880 shares of NovoCure worth $650K as of Q2 2026.
  • Creative Planning bought 22,137 NovoCure shares in Q2 2026, an estimated $335K.
  • NovoCure made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2985 holding.
  • Creative Planning first reported a position in NovoCure in Q4 2015 and has held it in 24 quarters since.
  • Creative Planning's NovoCure position peaked at $1M in Q4 2020.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.